ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

2026-07-24

READ MORE >

ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

2026-07-16

READ MORE >

NASDAQ - ANIP

$78.50

-0.03 (-0.04%)

Pricing delayed by 20 minutes
Last updated 2026-07-24 15:32:00